The complexity of Alzheimer's disease: an evolving puzzle.
Ferrari C, Sorbi S.
Physiol Rev. 2021 Jul 1;101(3):1047-1081. doi: 10.1152/physrev.00015.2020. Epub 2021 Jan 21.
Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS.
JAMA Neurol. 2014 Apr;71(4):505-8. doi: 10.1001/jamaneurol.2013.5847.
Microglia and amyloid plaque formation in Alzheimer's disease - Evidence, possible mechanisms, and future challenges.
Fruhwürth S, Zetterberg H, Paludan SR.
J Neuroimmunol. 2024 May 15;390:578342. doi: 10.1016/j.jneuroim.2024.578342. Epub 2024 Apr 4.
Spatially resolved mass spectrometry analysis of amyloid plaque-associated lipids.
Blank M, Hopf C.
J Neurochem. 2021 Oct;159(2):330-342. doi: 10.1111/jnc.15216. Epub 2020 Nov 1.
beta-Amyloid peptides and amyloid plaques in Alzheimer's disease.
Gouras GK, Olsson TT, Hansson O.
Neurotherapeutics. 2015 Jan;12(1):3-11. doi: 10.1007/s13311-014-0313-y.
Alzheimer's disease.
Blennow K, de Leon MJ, Zetterberg H.
Lancet. 2006 Jul 29;368(9533):387-403. doi: 10.1016/S0140-6736(06)69113-7.
Protein folding and misfolding.
Dobson CM.
Nature. 2003 Dec 18;426(6968):884-90. doi: 10.1038/nature02261.
Autophagy enables microglia to engage amyloid plaques and prevents microglial senescence.
Choi I, Wang M, Yoo S, Xu P, Seegobin SP, Li X, Han X, Wang Q, Peng J, Zhang B, Yue Z.
Nat Cell Biol. 2023 Jul;25(7):963-974. doi: 10.1038/s41556-023-01158-0. Epub 2023 May 25.
The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics.
Karran E, De Strooper B.
Nat Rev Drug Discov. 2022 Apr;21(4):306-318. doi: 10.1038/s41573-022-00391-w. Epub 2022 Feb 17.
Plaque fluid as a bacterial milieu.
Edgar WM, Higham SM.
J Dent Res. 1990 Jun;69(6):1332-6. doi: 10.1177/00220345900690062101.
